SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-23-011418
Filing Date
2023-07-24
Accepted
2023-07-24 17:09:26
Documents
2
Period of Report
2023-07-21

Document Format Files

Seq Description Document Type Size
1 form3-07242023_090720.html 3  
1 form3-07242023_090720.xml 3 1686
2 ex24-07242023_090721.htm EX-24 9225
  Complete submission text file 0001415889-23-011418.txt   12512
Mailing Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211
Business Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Issuer) CIK: 0001133869 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CAPRICOR THERAPEUTICS, INC. 10865 ROAD TO THE CURE, SUITE 150 SAN DIEGO CA 92121
Business Address
Gotwals Philip J (Reporting) CIK: 0001982655 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34058 | Film No.: 231105789